NCT06822634Recruiting
Advances in Imaging to Assess Response in Rectal Cancer
Advances in Imaging to Assess Response in Rectal Cancer (AIR-REC)
Source: ClinicalTrials.gov · Last updated 12 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to determine the feasibility of acquiring serial MRI images for advanced radiotherapy planning in colorectal patients. The main question it aims to answer: Is it feasible to acquire serial MR images for advanced radiotherapy planning for rectal cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 14 Jan 2025
- Start date
- 11 Nov 2024
- Primary completion date
- 26 Jun 2026
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Diseases
- Colorectal cancer
- NCT number
- NCT06822634
What you commit to
- Study type: Observational
- Planned participants: 20
- From 11 Nov 2024 to the primary completion date, 26 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contra-indications to MRI, such as claustrophobia, excessive body weight, MRI unsafe implants, ferrous metal in the body, insufficient information on prior surgeries. MRI conditional implants where conditions cannot be met (e.g pacemakers).
- Any previous radiotherapy to the pelvis.
- Major surgery within 28 days prior to trial entry.
Other illness
- Inflammatory bowel disease.
- Other severe or uncontrolled systemic disease or evidence of any other significant disorder or lab finding that makes it undesirable for the patient to participate in the study, as determined by the treating clinician.
- History of physical or psychiatric disorder that would prevent informed consent and compliance with the protocol.
Other
- Patients with de-functioning stoma.
Who the study is looking for
- Histologically confirmed rectal adenocarcinoma.
- T stage 3b or above and/or high risk factors eg. EMVI, nodal disease.
- Participant able to give written informed consent.
- Male or non-pregnant female ≥18 years of age.
- Scheduled to undergo radical radiotherapy.
- Patients willing and able to comply with the protocol for the duration of study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beatson West of Scotland Cancer Centre Coordinator of this site? Confirm its status | Glasgow | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.